187 related articles for article (PubMed ID: 15194457)
1. Control of vascular cell proliferation and migration by cyclin-dependent kinase signalling: new perspectives and therapeutic potential.
Andrés V
Cardiovasc Res; 2004 Jul; 63(1):11-21. PubMed ID: 15194457
[TBL] [Abstract][Full Text] [Related]
2. Coordinate control of proliferation and migration by the p27Kip1/cyclin-dependent kinase/retinoblastoma pathway in vascular smooth muscle cells and fibroblasts.
Díez-Juan A; Andrés V
Circ Res; 2003 Mar; 92(4):402-10. PubMed ID: 12600894
[TBL] [Abstract][Full Text] [Related]
3. Cip/Kip cyclin-dependent kinase inhibitors: brakes of the cell cycle engine during development.
Nakayama K; Nakayama K
Bioessays; 1998 Dec; 20(12):1020-9. PubMed ID: 10048302
[TBL] [Abstract][Full Text] [Related]
4. CDKs and CKIs: molecular targets for tissue remodelling.
Nabel EG
Nat Rev Drug Discov; 2002 Aug; 1(8):587-98. PubMed ID: 12402499
[TBL] [Abstract][Full Text] [Related]
5. The cell cycle and cardiovascular diseases.
Boehm M; Nabel EG
Prog Cell Cycle Res; 2003; 5():19-30. PubMed ID: 14593697
[TBL] [Abstract][Full Text] [Related]
6. ATP-noncompetitive inhibitors of CDK-cyclin complexes.
Orzáez M; Gortat A; Mondragón L; Bachs O; Pérez-Payá E
ChemMedChem; 2009 Jan; 4(1):19-24. PubMed ID: 19039815
[TBL] [Abstract][Full Text] [Related]
7. Inhibiting cyclin-dependent kinase/cyclin activity for the treatment of cancer and cardiovascular disease.
Ivorra C; Samyn H; Edo MD; Castro C; Sanz-González SM; Déez-Juan A; Andrés V
Curr Pharm Biotechnol; 2003 Feb; 4(1):21-37. PubMed ID: 12570680
[TBL] [Abstract][Full Text] [Related]
8. AP-1 blockade in breast cancer cells causes cell cycle arrest by suppressing G1 cyclin expression and reducing cyclin-dependent kinase activity.
Liu Y; Lu C; Shen Q; Munoz-Medellin D; Kim H; Brown PH
Oncogene; 2004 Oct; 23(50):8238-46. PubMed ID: 15378019
[TBL] [Abstract][Full Text] [Related]
9. Cyclins and related kinases in cancer cells.
Malumbres M
J BUON; 2007 Sep; 12 Suppl 1():S45-52. PubMed ID: 17935277
[TBL] [Abstract][Full Text] [Related]
10. Paradigms of growth control: relation to Cdk activation.
Olashaw N; Pledger WJ
Sci STKE; 2002 May; 2002(134):re7. PubMed ID: 12034920
[TBL] [Abstract][Full Text] [Related]
11. Granulosa cell expression of G1/S phase cyclins and cyclin-dependent kinases in PMSG-induced follicle growth.
Cannon JD; Cherian-Shaw M; Lovekamp-Swan T; Chaffin CL
Mol Cell Endocrinol; 2007 Jan; 264(1-2):6-15. PubMed ID: 17084963
[TBL] [Abstract][Full Text] [Related]
12. Cell cycle regulators and hematopoiesis.
Steinman RA
Oncogene; 2002 May; 21(21):3403-13. PubMed ID: 12032778
[TBL] [Abstract][Full Text] [Related]
13. Multiple levels of cyclin specificity in cell-cycle control.
Bloom J; Cross FR
Nat Rev Mol Cell Biol; 2007 Feb; 8(2):149-60. PubMed ID: 17245415
[TBL] [Abstract][Full Text] [Related]
14. CDK activation by non-cyclin proteins.
Nebreda AR
Curr Opin Cell Biol; 2006 Apr; 18(2):192-8. PubMed ID: 16488127
[TBL] [Abstract][Full Text] [Related]
15. Novel potent pharmacological cyclin-dependent kinase inhibitors.
Węsierska-Gądek J; Chamrád I; Kryštof V
Future Med Chem; 2009 Dec; 1(9):1561-81. PubMed ID: 21425979
[TBL] [Abstract][Full Text] [Related]
16. New concepts regarding focal adhesion kinase promotion of cell migration and proliferation.
Cox BD; Natarajan M; Stettner MR; Gladson CL
J Cell Biochem; 2006 Sep; 99(1):35-52. PubMed ID: 16823799
[TBL] [Abstract][Full Text] [Related]
17. Cell cycle regulation of the mammalian CDK activator RINGO/Speedy A.
Dinarina A; Santamaria PG; Nebreda AR
FEBS Lett; 2009 Sep; 583(17):2772-8. PubMed ID: 19622356
[TBL] [Abstract][Full Text] [Related]
18. Pho85, a multifunctional cyclin-dependent protein kinase in budding yeast.
Huang D; Friesen H; Andrews B
Mol Microbiol; 2007 Oct; 66(2):303-14. PubMed ID: 17850263
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the cytoskeleton: an oncogenic function for CDK inhibitors?
Besson A; Assoian RK; Roberts JM
Nat Rev Cancer; 2004 Dec; 4(12):948-55. PubMed ID: 15573116
[TBL] [Abstract][Full Text] [Related]
20. Activation of an alfalfa cyclin-dependent kinase inhibitor by calmodulin-like domain protein kinase.
Pettkó-Szandtner A; Mészáros T; Horváth GV; Bakó L; Csordás-Tóth E; Blastyák A; Zhiponova M; Miskolczi P; Dudits D
Plant J; 2006 Apr; 46(1):111-23. PubMed ID: 16553899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
